Improving HEDIS? Rate Analysis and Performance with Better Data Management

A national health plan cut data processing from hours to just 30 minutes, turning inefficiencies into actionable insights.

With 100+ data extracts monthly and reduced rework, they streamlined operations, enhanced quality measures, and improved decision-making.

By centralizing clinical, claims, and hybrid data, teams now access real-time insights in one place, driving better outcomes, smarter strategies, and significant time savings. Discover what you can achieve with a more efficient data approach.

Accelerating Clinical Trial Recruitment: Why Speed Matters and How to Achieve it in Patient Recruitment

Bringing new therapies to market is critical, but slow patient recruitment is a major roadblock. With most trials missing enrollment targets, outdated processes delay life-saving treatments.

The good news? AI-driven, real-time EHR integration is transforming enrollment. Learn how sponsors can cut screening time by 75%, streamline eligibility checks, and accelerate market readiness.

Unstructured Healthcare Data: A Closer Look With Snowflake

Data has always been valuable in healthcare, but organizations are only now recognizing the differences beyond basic classifications like claims, labs, or SDOH.

What are the unique forms of data? In this INOvators episode, Patrick Kovalik , Industry Principal for Healthcare & Life Sciences at Snowflake , dives into the different data types and the distinct value each brings to transforming healthcare. Watch the video podcast here.

Journey of the Pharmacy Industry: Past, Present, and Future

How has pharmacy evolved over the past few decades, and where is it headed next? Wilson Tam PharmD , Director of Sales Engineering at Inovalon, sat down with the founder of MERx Pharmacy Consulting, LLC , Michael Einodshofer , RPh, MBA, to discuss pharmacy’s transformation and the challenges ahead.

From the evolution of HIV medications to the future of gene therapies, vertical integration, and accelerating access to specialty drugs, they tackled the biggest issues shaping the industry today. Watch the discussion here.

Keith Dunleavy, M.D., Founder and CEO to Retire, Transition to Board of Directors. Adam Kansler Appointed as CEO for Next Phase of the Company’s Growth.

Read the press release here, and watch the journey unfold in this special tribute video.